Maintenance fees coming due
5 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Nov 30, 2026. Unpaid by Jun 1, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,661,441 | Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 · High confidence | Apellis Pharmaceuticals, Inc. | In force | Nov 30, 2026 | Jun 1, 2027 | High confidence | |
| US 10,308,687 | Cell-Penetrating Compstatin Analogs and Uses Thereof In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Apellis Pharmaceuticals, Inc. | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 11,712,460 | Methods of Treating Chronic Disorders with Complement Inhibitors In force Fee due Feb 1, 2027 Lapses if unpaid Aug 2, 2027 · High confidence | Apellis Pharmaceuticals, Inc. | In force | Feb 1, 2027 | Aug 2, 2027 | High confidence | |
| US 11,844,841 | Dosing Regimens and Related Compositions and Methods In force Fee due Jun 19, 2027 Lapses if unpaid Dec 20, 2027 · Medium confidence | Apellis Pharmaceuticals, Inc. | In force | Jun 19, 2027 | Dec 20, 2027 | Medium confidence | |
| US 11,903,994 | Dosing Regimens In force Fee due Aug 20, 2027 Lapses if unpaid Feb 22, 2028 · High confidence | Apellis Pharmaceuticals, Inc. | In force | Aug 20, 2027 | Feb 22, 2028 | High confidence |
5 of 5 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.